课题基金 / 基金详情

The Application of Novel Cements in Concrete Block Manufacturing Towards Low Carbon-High Strength Masonry

The Application of Novel Cements in Concrete Block Manufacturing Towards Low Carbon-High Strength Masonry
新型水泥在混凝土砌块制造中的应用走向低碳高强砌体
批准号:
543432-2019
负责人:
Shrive, Nigel
金额:
$8.89万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Research and Development Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-01-01 至 2022-12-31

项目摘要

项目成果

Shrive, Nigel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose to develop new cements for concrete block production with much less associated Greenhouse gas emission and with higher strength. Normal strength blocks manufactured with the novel cements will have much lower associated GHG than the stronger blocks. The novel cements will be produced by using supplementary cementitious materials which include reactive metakaolin and a seeding material to encourage the production of calcium-(alumino-)silicate-hydrate, the primary binding phase in cement paste, with specific properties. Recognizing that nano-cements produce very high strength, grinding the novel cements to a much smaller average size will produce high strength concretes. There are two main objectives of the research. The first is to determine concrete mixes with novel cements that can replace current production and thereby reduce the greenhouse gas emissions associated with "standard" concrete block masonry. The second is to use novel cements to produce high strength blocks that can be used to build bigger and stronger structures from concrete blockwork and thereby expand the use of masonry, and reduce construction costs. This may require the formulation of a mortar compatible with the high strength block to achieve high strength masonry. In addition, taking full advantage of the new blocks could be limited by the current restrictions on tall wall design in the Canadian masonry standard. Recent work has shown that the way tall walls are designed following the procedure in the current standard is very conservative and not very accurate compared to test results or other standards around the world. Therefore there is a need to examine the methods used in the current standard and determine how to update them so they allow more effective use of masonry in general, but in particular, they encourage full and effective use of the high strength blocks in the construction of tall walls. The proposal is supported by the Canadian Concrete Masonry Producers Association whose members will benefit from the ability to market both "greener" and stronger concrete blocks. The Canada Masonry Design Centre also supports the application and will benefit through increased work for its contractor members.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strength and Long-term Behaviour of Masonry
  • 批准号:
    RGPIN-2018-03772
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $6.27万
  • 财政年份:
    2022
  • 负责人:
    Shrive, Nigel
  • 依托单位:
Strength and Long-term Behaviour of Masonry
  • 批准号:
    RGPIN-2018-03772
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.13万
  • 财政年份:
    2021
  • 负责人:
    Shrive, Nigel
  • 依托单位:
The Application of Novel Cements in Concrete Block Manufacturing Towards Low Carbon-High Strength Masonry
  • 批准号:
    543432-2019
  • 项目类别:
    Collaborative Research and Development Grants
  • 资助金额:
    $10.71万
  • 财政年份:
    2020
  • 负责人:
    Shrive, Nigel
  • 依托单位:
Strength and Long-term Behaviour of Masonry
  • 批准号:
    RGPIN-2018-03772
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.13万
  • 财政年份:
    2020
  • 负责人:
    Shrive, Nigel
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: